- STAT+: Trump administration pursues more durable changes to science policy after setbacks in courtThe White House has proposed sweeping changes to the bedrock regulation undergirding all federal contracts, empowering the executive branch to direct research, terminate grants, and external scient…STAT · 19d ago↗ source
- Vertex's Crinetics deal points to big ambitions for cystic fibrosis leaderVertex Pharmaceuticals' $10 billion acquisition of an endocrinology startup represents the company’s clearest and boldest step toward the upper echelon of the biopharma industry. Long a biotech s…Endpoints · 20d ago↗ source
- Tampa General kicks off legal fight over Lilly's 340B restrictionsTampa General Hospital sued Eli Lilly for halting its 340B discounts, kicking off a broader fight over whether pharmaceutical companies can condition drug discounts on new claims data requirements.…